» Authors » Eva Van Braeckel

Eva Van Braeckel

Explore the profile of Eva Van Braeckel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 1526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Duthoo E, Beyls E, Backers L, Gudjonsson T, Huang P, Jonckheere L, et al.
J Exp Med . 2025 Mar; 222(5). PMID: 40029331
Ataxia telangiectasia and Rad3-related (ATR) kinase and its interacting protein ATRIP orchestrate the replication stress response. Homozygous splice variants in the ATRIP gene, resulting in ATRIP deficiency, were identified in...
2.
Goeteyn E, Taylor S, Dicker A, Bolle L, Wauters M, Joossens M, et al.
Respir Res . 2024 Oct; 25(1):368. PMID: 39395980
Background: Chronic airway disease (CAD) is characterized by chronic airway inflammation and colonization of the lungs by pro-inflammatory pathogens. However, while various other bacterial species are present in the lower...
3.
Willems E, Hamerlinck H, Messiaen A, Schelstraete P, Van Braeckel E, Vande Weygaerde Y, et al.
Acta Clin Belg . 2024 Aug; :1-7. PMID: 39101268
Objectives: This study aimed to evaluate an expanded matrix-assisted laser desorption-ionization-time of flight mass spectrometry (MALDI-TOF MS) database for the identification of species other than (Hi). Methods: A total of...
4.
Drysdale M, Hautekiet T, Singh M, Hautekiet J, Ludikhuyze L, Patel V, et al.
Acta Clin Belg . 2024 Jul; 79(3):174-183. PMID: 39081095
Objective: Sotrovimab, a dual-action, engineered human monoclonal antibody, has been demonstrated to significantly reduce the risk of hospitalisation and death in high-risk patients with COVID-19. Here, we describe the real-world...
5.
Grassi L, Asfahl K, Van den Bossche S, Maenhout I, Sass A, Vande Weygaerde Y, et al.
Biofilm . 2024 Jul; 7:100206. PMID: 38975276
It is increasingly recognized that interspecies interactions may modulate the pathogenicity of during chronic lung infections. Nevertheless, while the interaction between and pathogenic microorganisms co-infecting the lungs has been widely...
6.
Van Braeckel E, Bosteels C
Eur Respir Rev . 2024 Jul; 33(173). PMID: 38960614
Bronchiectasis and nontuberculous mycobacteria (NTM) are intricately intertwined, with NTM capable of being both a cause and consequence of bronchiectatic disease. This narrative review focuses on the common ground of...
7.
Aliberti S, Ringshausen F, Dhar R, Haworth C, Loebinger M, Dimakou K, et al.
Eur Respir J . 2024 Apr; 63(4). PMID: 38609095
Background: A validated 4-point sputum colour chart can be used to objectively evaluate the levels of airway inflammation in bronchiectasis patients. In the European Bronchiectasis Registry (EMBARC), we tested whether...
8.
Janssens E, Huygens S, Moors I, Delie A, Kerre T, Vande Weygaerde Y, et al.
Mycoses . 2024 Mar; 67(3):e13715. PMID: 38477367
Background: Invasive pulmonary aspergillosis (IPA) is a relatively common infection in patients with acute myeloid leukaemia (AML), and is associated with high mortality rates. Optimising early detection is key to...
9.
Polverino E, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger M, et al.
J Allergy Clin Immunol . 2024 Feb; 153(6):1553-1562. PMID: 38401857
Background: Asthma is commonly reported in patients with a diagnosis of bronchiectasis. Objective: The aim of this study was to evaluate whether patients with bronchiectasis and asthma (BE+A) had a...
10.
Janssens I, Lambrecht B, Van Braeckel E
Semin Respir Crit Care Med . 2024 Jan; 45(1):3-20. PMID: 38286136
The filamentous fungus causes a wide spectrum of diseases in the human lung, with being the most pathogenic and allergenic subspecies. The broad range of clinical syndromes that can develop...